№ lp_1_2_53091
File format: docx
Character count: 4091
File size: 60 KB
This document outlines safety protocols and handling procedures for using Piranha solution in a laboratory setting.
Year:
Not specified
Region / City:
Not specified
Topic:
Chemical safety, laboratory procedures
Document type:
Standard Operating Procedure
Agency / Institution:
Not specified
Author:
Not specified
Target audience:
Laboratory personnel, researchers handling hazardous chemicals
Effective period:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2026
Region / City:
Global
Topic:
Semiconductor device fabrication
Document Type:
Conference agenda
Organization / Institution:
imec, GLOBALFOUNDRIES, CEA-Leti, Univ. of North Texas, Technic France, Toshiba, Avantor, Versum, Kurita, Entegris, Hilltop Economics LLC, Hanyang University, Dupont, QuantumClean, Air Liquide
Author:
Various presenters from academia and industry
Target Audience:
Semiconductor manufacturing professionals, engineers, researchers
Date of Approval:
2026
Date of Changes:
None
Period of Activity:
2026
Description:
Agenda for a technical conference discussing various semiconductor fabrication processes and challenges, including etching, cleaning, and surface preparation for advanced nodes.
Department:
Choose a department
Principal Investigator:
PI name
Group Safety Coordinator/Lab Manager:
Name of safety contact
SOP written by:
CoE SOP Committee
Date of this version:
Not specified
Date approved by PI/Lab Supervisor:
Not specified
Type of SOP:
Hazardous material
Chemical Substances Covered:
Hydrofluoric acid (HF), Buffered Oxide Etch (BOE), ammonium fluoride, sodium fluoride, ammonium hydrogen difluoride
Hazard Classification:
Corrosive, highly toxic
Intended Use:
Research laboratories
Required Approval:
Principal Investigator
Required Training:
Hands-on laboratory safety training
Required Equipment:
Chemical fume hood, emergency shower, eye wash, calcium gluconate kit
Storage Requirements:
Separate from bases and incompatible materials; not in glass containers
Document Sections:
Purpose, Key Points, Hazard Awareness, Emergency Response, Storage, Work Practices and Engineering Controls, PPE, Detailed Procedures, Waste Disposal, Training Record
Institutional Context:
Laboratory Safety Manual and Chemical Hygiene Plan
Year:
2017
Region / city:
Eatontown, NJ
Subject:
Enterprise Infrastructure Solution (EIS) Management Software Request for Information (RFI)
Type of document:
Request for Information (RFI)
Organization / institution:
Department of Veterans Affairs, Technology Acquisition Center
Author:
Michael Frank
Target audience:
Contractors in telecommunications and related services
Period of validity:
August 30, 2017
Approval date:
August 30, 2017
Date of modifications:
None
Year:
2025
Region / city:
Centurion, Cape Town
Theme:
Email cleansing solution, maintenance, support, service delivery
Document type:
Request for Proposal (RFP)
Organization / institution:
SITA
Author:
SITA
Target audience:
Suppliers, bidders, technical service providers
Duration:
5 years
Approval date:
Not specified
Modification date:
Not specified
Year:
2019
Region / City:
United States
Topic:
Information Technology, Veterans Affairs, Healthcare
Document Type:
Performance Work Statement
Agency / Institution:
Department of Veterans Affairs, Office of Information & Technology
Author:
Not specified
Target Audience:
Contractors, VA staff, IT professionals
Period of Effectiveness:
June 27, 2019, onwards
Approval Date:
June 27, 2019
Amendments Date:
Not specified
Public Notice Number:
MOLIT Public Notice No. 2026-099
Issuing Authority:
Ministry of Land, Infrastructure and Transport
Country:
Republic of Korea
Program Name:
K-City Network Global Cooperation Program
Program Type:
Smart solution demonstration grant program
Legal Basis:
Act on the Promotion of Smart City Development and Industry, Article 30
Year:
2026
Announcement Date:
January 28, 2026
Application Period:
January 28, 2026 – March 17, 2026
Application Deadline:
March 17, 2026, 5:00 p.m. KST
Implementing Agency:
Korea Agency for Infrastructure Technology Advancement
Program Secretariat:
K-City Network Secretariat
Eligible Applicants:
Korean businesses and organizations
Consortium Requirement:
Mandatory consortium with overseas partner governments
Required Documents:
Project proposal, Letter of Intent or Memorandum of Understanding
Funding Amount:
300 million to 400 million KRW per project
Number of Selected Projects:
Up to six
Target Areas:
Transportation, energy, environment, security, urban administration
Geographical Scope:
Overseas cities and countries
Evaluation Method:
Proposal review and oral presentation
Contact Email:
[email protected]
Contact Telephone:
+82-31-389-6359, +82-31-389-6409
Year:
2024
Region / City:
Pretoria
Topic:
Procurement of Network Access Control (NAC) Solution
Document Type:
Bid Specification
Organization:
SITA
Author:
Not specified
Target Audience:
Suppliers / Bidders
Validity Period:
200 Days from the Closing Date
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2026
Region / City:
European Union
Subject:
Pharmaceutical Product Information
Document Type:
Pharmaceutical Summary
Organization:
European Medicines Agency
Author:
European Medicines Agency
Target Audience:
Healthcare professionals
Period of validity:
Ongoing
Approval Date:
2026
Date of Modifications:
2026
Contextual Description:
The document outlines the product characteristics, indications, dosage, administration guidelines, and precautions for the pharmaceutical product Tysabri, as approved by the European Medicines Agency.
Year:
2025
Region / City:
Australia
Topic:
Pharmaceutical submission for drug listing
Document Type:
Pharmaceutical submission
Organization:
Janssen-Cilag Pty Ltd
Author:
Not specified
Target Audience:
Healthcare professionals, regulatory authorities
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
March 2025
Note:
Context
Year:
2026
Region / City:
EMEA
Subject:
Pharmaceutical Information
Document Type:
Product Information
Organization / Institution:
European Medicines Agency
Author:
European Medicines Agency
Target Audience:
Healthcare Professionals, Medical Practitioners
Validity Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2023
Region / City:
Australia
Subject:
Chronic migraine, medicinal product submission
Document type:
Submission for PBS listing
Organization:
Novartis Pharmaceuticals Australia Pty. Limited
Author:
Not specified
Target audience:
Health professionals, pharmaceutical regulatory bodies
Period of validity:
Not specified
Date of approval:
2 July 2018
Date of amendments:
November 2023
Year:
2024
Region / City:
Australia
Topic:
Immunization, Respiratory Syncytial Virus (RSV), Vaccines
Document Type:
Submission
Organization:
SANOFI-AVENTIS AUSTRALIA PTY LTD
Author:
Not specified
Target Audience:
Healthcare professionals, policy makers, immunization program administrators
Period of validity:
From 2024
Approval Date:
24 November 2023
Date of Changes:
17 January 2025
Date of Submission:
7 March 2024
Note:
Contextual Description
Year:
2012
Note:
Region / City
Topic:
High Availability, Disaster Recovery
Document Type:
Technical Article
Author:
Joseph Sack, Sanjay Mishra
Target Audience:
Operational SQL Server database administrators, technology architects, system administrators
Copyright:
© 2012 Microsoft. All rights reserved.
Year:
2007
Region / City:
Global
Theme:
Innovation, Business Process Management, Technology Solutions
Document Type:
White Paper
Organization / Institution:
Microsoft
Author:
Not specified
Target Audience:
Business executives, innovation managers, IT decision-makers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2022
Region / City:
Australia
Topic:
Medical treatment approval and submission for pembrolizumab and lenvatinib
Document type:
Submission for drug listing
Organization / Institution:
Pharmaceutical Benefits Advisory Committee (PBAC), Therapeutic Goods Administration (TGA)
Author:
Merck Sharp & Dohme (Australia) Pty Ltd
Target audience:
Medical professionals, health regulators
Period of validity:
2022 onward
Approval date:
August 10, 2021
Amendment date:
Not specified
A1 ICAM Solution Instructions for Non-CAC Access to MyVECTOR, June 2023 (v1.0, updated 28 July 2023)
Year:
2023
Organization:
United States Air Force A1
Program:
A1 Digital Transformation Activity (DTA)
System:
MyVECTOR
Subject:
Identity, Credential, and Access Management (ICAM)
Access Method:
Non-CAC access via Login.gov and Okta Verify
Intended Users:
U.S. Government personnel and authorized contractors without CAC
Distribution Statement:
C; D
Classification:
Unclassified; may contain Controlled Unclassified Information (CUI)
Version:
1.0
Initial Release Date:
June 2023
Last Update:
28 July 2023
Authentication Requirements:
Two-factor authentication; identity verification
Contact Information:
A1 Service Desk